If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might ...